STOCK TITAN

SolarEdge Appoints New Directors to its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

SolarEdge Technologies (SEDG) has announced two new appointments to its Board of Directors, effective January 6, 2025. Yoram Tietz, a Senior Advisor to General Atlantic and former Managing Partner of EY Israel, will chair the Board's Audit Committee. Gilad Almogy, Founder and CEO of Ultima Genomics, will join the Board's Technology Committee.

Tietz brings extensive experience from his 27-year tenure at Ernst & Young, including 15+ years as Managing Partner of EY Israel and leadership of its High-Tech Cluster. Almogy, founder of Ultima Genomics and previously Cogenra Solar, brings significant technological expertise with over 80 US Patents and past leadership roles at Applied Materials, where he managed a $1 billion+ revenue business.

SolarEdge Technologies (SEDG) ha annunciato due nuove nomine per il suo Consiglio di Amministrazione, a partire dal 6 gennaio 2025. Yoram Tietz, Senior Advisor di General Atlantic e ex Managing Partner di EY Israele, presiederà il Comitato di Auditing del Consiglio. Gilad Almogy, Fondatore e CEO di Ultima Genomics, entrerà a far parte del Comitato Tecnologico del Consiglio.

Tietz porta un'esperienza approfondita derivante dai suoi 27 anni di carriera presso Ernst & Young, inclusi oltre 15 anni come Managing Partner di EY Israele e la guida del suo High-Tech Cluster. Almogy, fondatore di Ultima Genomics e precedentemente Cogenra Solar, apporta una significativa esperienza tecnologica con oltre 80 brevetti statunitensi e precedenti ruoli di leadership presso Applied Materials, dove ha gestito un'attività con oltre 1 miliardo di dollari di fatturato.

SolarEdge Technologies (SEDG) ha anunciado dos nuevos nombramientos para su Junta Directiva, que entrarán en vigencia el 6 de enero de 2025. Yoram Tietz, Consejero Senior de General Atlantic y ex Socio Director de EY Israel, presidirá el Comité de Auditoría de la Junta. Gilad Almogy, Fundador y CEO de Ultima Genomics, se unirá al Comité de Tecnología de la Junta.

Tietz aporta una amplia experiencia de sus 27 años en Ernst & Young, incluidos más de 15 años como Socio Director de EY Israel y liderazgo en su Cluster de Alta Tecnología. Almogy, fundador de Ultima Genomics y anteriormente de Cogenra Solar, aporta una notable experiencia tecnológica con más de 80 patentes en EE. UU. y roles de liderazgo anteriores en Applied Materials, donde gestionó un negocio con más de 1 mil millones de dólares en ingresos.

SolarEdge Technologies (SEDG)는 2025년 1월 6일부로 이사회를 새롭게 구성한다고 발표했습니다. Yoram Tietz는 General Atlantic의 수석 자문이자 EY 이스라엘의 전 관리 파트너로서 이사회 감사위원회 회장을 맡게 됩니다. Gilad Almogy는 Ultima Genomics의 창립자이자 CEO로서 이사회의 기술 위원회에 합류합니다.

Tietz는 Ernst & Young에서 27년 이상 근무한 경험이 있으며, EY 이스라엘의 관리 파트너로 15년 이상 활동하며 하이테크 클러스터를 이끌었습니다. Almogy는 Ultima Genomics의 창립자이자 이전에 Cogenra Solar의 CEO로 활동하며, 80개 이상의 미국 특허와 Applied Materials에서 처리한 10억 달러 이상의 수익을 올리는 사업을 이끌었던 기술 전문성을 보유하고 있습니다.

SolarEdge Technologies (SEDG) a annoncé deux nouvelles nominations au sein de son Conseil d'Administration, prenant effet le 6 janvier 2025. Yoram Tietz, Conseiller Senior auprès de General Atlantic et ancien Associé Gérant d'EY Israël, présidera le Comité d'Audit du Conseil. Gilad Almogy, Fondateur et CEO d'Ultima Genomics, rejoindra le Comité de Technologie du Conseil.

Tietz apporte une expérience considérable de ses 27 années passées chez Ernst & Young, dont plus de 15 ans en tant qu'Associé Gérant d'EY Israël, ainsi que le leadership de son Cluster High-Tech. Almogy, fondateur d'Ultima Genomics et anciennement dirigeant de Cogenra Solar, apporte une expertise technologique significative avec plus de 80 brevets américains et a occupé des postes de direction chez Applied Materials, où il a géré une entreprise générant plus de 1 milliard de dollars de revenus.

SolarEdge Technologies (SEDG) hat zwei neue Ernennungen für seinen Vorstand angekündigt, die am 6. Januar 2025 wirksam werden. Yoram Tietz, Senior Advisor bei General Atlantic und ehemaliger Managing Partner von EY Israel, wird den Prüfungsausschuss des Vorstands leiten. Gilad Almogy, Gründer und CEO von Ultima Genomics, wird dem Technologieausschuss des Vorstands beitreten.

Tietz bringt umfangreiche Erfahrungen aus seinen 27 Jahren bei Ernst & Young mit, darunter mehr als 15 Jahre als Managing Partner von EY Israel und die Leitung seines High-Tech-Clusters. Almogy, Gründer von Ultima Genomics und zuvor CEO von Cogenra Solar, verfügt über bedeutende technologische Expertise mit über 80 US-Patenten und früheren Führungspositionen bei Applied Materials, wo er ein Geschäft mit über 1 Milliarde US-Dollar Umsatz leitete.

Positive
  • Addition of experienced executives with strong financial and technological backgrounds
  • Appointment of former EY Managing Partner to chair Audit Committee strengthens financial oversight
  • Addition of technology expert with proven track record in solar industry (Cogenra Solar)
Negative
  • None.

MILPITAS, Calif.--(BUSINESS WIRE)-- SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, today announced the appointment of Yoram Tietz and Gilad Almogy to its Board of Directors, effective January 6, 2025. Mr. Tietz has been appointed as chair the Board’s Audit Committee, while Mr. Almogy joined the Board’s Technology Committee.

Yoram Tietz is a Senior Advisor to General Atlantic, a leading global growth equity investment fund where he provides strategic support and counsel for General Atlantic’s investing platform in Israel. Prior to joining General Atlantic, Mr. Tietz spent 27 years at Ernst & Young (EY), including more than 15 years as Managing Partner of EY Israel. Prior to his role as Managing Partner, he was Head of High-Tech Cluster at EY Israel from 2000 to 2007, where he advised and counseled many Israeli tech founders and CEOs.

Mr. Tietz is the Chairman of the Friends of Sheba Medical Center. He advises Sheba’s Management on innovation and transformation and is a director at Sheba Impact Ltd. – Sheba’s TTO. In addition to Sheba, Mr. Tietz is also actively involved in community and philanthropic initiatives as Co-Founder and Chairman of Birthright Excel.

Gilad Almogy is the Founder and CEO of Ultima Genomics, provider of the first $100 human genome sequencing solution. Mr. Almogy founded Ultima Genomics in 2016 with a mission to continuously reduce the cost of genomic sequencing and expand its access to enable the era of Omics data-driven healthcare.

Previously, Mr. Almogy was the Founder and CEO of Cogenra Solar, a developer of record breaking shingled solar modules, with multiple gigawatts deployed worldwide to date. He led Cogenra from inception until its acquisition by SunPower (Nasdaq: SPWR) in 2015.

Before Cogenra, Mr. Almogy was a senior vice president for Applied Materials (Nasdaq: AMAT) where he led the Process Diagnostic and Control Group and later the Display Group, a more than $1 billion per year revenue business. He joined Applied Materials through its acquisition of Orbot in 1997. While at Orbot and Applied Materials, Mr. Almogy led the development of wafer inspection systems that are now widely adopted in semiconductor fabs worldwide.

Mr. Almogy earned a PhD in Applied Physics from the California Institute of Technology and a BSc in Mathematics and Physics from the Hebrew University in Jerusalem’s Talpiot program. He is the inventor of more than 80 US Patents.

“We are pleased to welcome both Yoram Tietz and Gilad Almogy to our Board of Directors,” said Avery More, Chairman of the Board. “The addition of seasoned executives serves to strengthen our Board, and we look forward to benefitting from both Gilad and Yoram’s insights as we shape our financial and strategic objectives. Their diverse experience across financial and technology disciplines will undoubtedly contribute to our Boardroom discussions as we continue to advance SolarEdge’s vision to create a world powered by clean, sustainable energy.”

About SolarEdge

SolarEdge is a global leader in smart energy technology. By leveraging world-class engineering capabilities and with a relentless focus on innovation, SolarEdge creates smart energy solutions that power our lives and drive future progress. SolarEdge developed an intelligent inverter solution that changed the way power is harvested and managed in photovoltaic (PV) systems. The SolarEdge DC optimized inverter seeks to maximize power generation while lowering the cost of energy produced by the PV system. Continuing to advance smart energy, SolarEdge addresses a broad range of energy market segments through its PV, storage, EV charging, batteries, and grid services solutions. SolarEdge is online at www.solaredge.com

Investor Contacts

SolarEdge Technologies, Inc.

JB Lowe, Head of Investor Relations

investors@solaredge.com

Sapphire Investor Relations, LLC

Erica Mannion or Michael Funari

investors@solaredge.com

Source: SolarEdge Technologies, Inc.

FAQ

When will the new directors join SolarEdge's (SEDG) Board of Directors?

Yoram Tietz and Gilad Almogy will join SolarEdge's Board of Directors effective January 6, 2025.

What role will Yoram Tietz have on SolarEdge's (SEDG) Board?

Yoram Tietz will serve as chair of the Board's Audit Committee.

What is Gilad Almogy's role in SolarEdge's (SEDG) Board?

Gilad Almogy will join the Board's Technology Committee.

What is Gilad Almogy's experience in the solar industry prior to joining SEDG's Board?

Almogy was the Founder and CEO of Cogenra Solar, a developer of record-breaking shingled solar modules, which was acquired by SunPower in 2015.

What is Yoram Tietz's background before joining SEDG's Board?

Tietz spent 27 years at Ernst & Young, including over 15 years as Managing Partner of EY Israel, and is currently a Senior Advisor to General Atlantic.

SunPower Corporation

NASDAQ:SPWR

SPWR Rankings

SPWR Latest News

SPWR Stock Data

21.55M
217.23M
0.71%
139%
16.39%
Solar
Semiconductors & Related Devices
Link
United States of America
RICHMOND